Biotechnology Perspective of Animals Diseases

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture
Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicineMolecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely
To Know More - Biotechnology Perspective of Animals Diseases

Bioinformatics Technologies and Global Markets

BCC Research’s goal for this study is to provide a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high-throughput ‘omic technologies and computer-enabled technologies that have driven the field forward. It examines the market trends and analysis regarding industry service providers, software solution developers, and IT and bioinformatics service providers that support the pharma industry.
Since the Human Genome Project was completed in April 2003, genome-wide association studies (GWAS) have contributed toward a greater understanding of the genetic basis of complex diseases and advances in high-throughput technologies. This has enabled researchers to rapidly map the genome of vertebrates, invertebrates and pathogens through cost-effective methods.More recently, improvements in cloud computing capabilities and advances in data-analysis software services have helped to expand the evaluation of available datasets, allowing researchers to build systems biology models of various diseases. Still, the challenge to translate this wealth of information into tangible clinical benefits, to support the development of new therapeutic interventions and to reduce the current prohibitively high cost of drug development remains.
 To Know More - Bioinformatics Technologies and Global Markets

Stem Cell Banking Market in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion

Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) in 2013. The current stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies.Many factors have actively contributing towards this overwhelming success stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters. To Know More - Stem Cell Banking Market

Central Nervous System (CNS) Biomarkers

In-depth interviews were conducted with leading experts in the field who are executives in companies, industry analysts and leading individuals in the field.The CNS biomarker and drug markets comprise drug products for treatment of a number of specific diseases afflicting both men and women. For completeness, the current and forecasted markets comprise the total market opportunity for each respective segment.Information to prepare this report was obtained from participating and emerging companies in the biomarker and CNS drug areas and from the following institutes within the National Institutes of Health (NIH): National Institute of Mental Health (NIMH), the National Institute of Aging (NIA), the National Institute of Neurological Diseases and Stroke (NINDS), National Human Genomic Research Institute (NHGRI), the NIH’s Center of Information Technology (CIT) and the National Library of Medicine (NLM).Additional information was obtained from a variety of medical and technical journals on the various specialties within biomarker and CNS applications. Other sources included the New York Times, Wall Street Journal, Washington Post, other newspapers, company documents and Internet websites. Population estimates are based on those reported by the International Data Base of the U.S. Census Bureau. Statistical data was obtained from the World Health Organization (WHO) and the Collaborating Centre for Drug Statistics Methodology (Norway).
To Know More -Central Nervous System (CNS) Biomarkers

India Stem Cell Banking market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million)

Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued at more than INR 400 Crore (US$ 70 Million) in 2013. The current stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies.Many factors have actively contributing towards this overwhelming success stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters.

To Know More -India Stem Cell Banking market

Animal Biotechnology - Technologies, Markets

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.There is discussion of in vitro meat production by culture

Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever, avian flu and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.RNA interference technology is now being applied for research in veterinary medicine
To Know More - Animal Biotechnology - Technologies, Markets

Biotechnology Products Markets in China

China's demand for biotechnology products has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in China are profiled.
To Know More - Biotechnology Products Markets in China